References

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753584/
  2. GenVisc850 Package Insert
  3. Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la Serna AR, Naranjo A, Gimeno M, Herrero-Beaumont G; AMELIA study group. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry- over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70: 1957-62.

4-7. GenVisc850 Package Insert

8.  Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la Serna AR, Naranjo A, Gimeno M, Herrero-Beaumont G; AMELIA study group. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry- over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70: 1957-62.

9. GenVisc850 Package Insert

10-12. TriVisc Package Insert 

13- 14. FDA summary of safety and effectiveness data (SSED). TriVisc® http://www.accesdata.fda.gov/cdrh_docs/pdf14/p140005b.pdf

15. Ulucay, I. et al. Acta Orthop Traumatol Turc 2007;41: 337-342. The use of arthroscopic debridement and viscosupplementation in knee osteoarthritis; 

16. Dıraçöglu, D. et al. J Back and Musculo Rehab. 2016;16: 53. Single versus multiple dose hyaluronic acid: Comparison of the results.; 

17. ÖzgÖnenel, L. et. al. Istanbul Tıp Dergisi 2008:1 ;53-57. Comparison of Different Hyaluronates

18.-19.  TriVisc Package Insert 

20. GenVisc850 Package Insert

21. TriVisc Package Insert